{"entity":{"id":"nct06223841","kind":"trial","name":"A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors","aka":[],"tldr":"A phase 1/2 trial of IAP0971 in advanced solid tumours, run by SUNHO（China）BioPharmaceutical CO., Ltd., now recruiting.","summary":"A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors is a phase 1/2 interventional study registered as NCT06223841 by SUNHO（China）BioPharmaceutical CO., Ltd., with 50 participants planned, started 2024-03-01 and due to reach its primary completion in 2026-03-01. Interventions recorded: IAP0971.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06223841","url":"https://clinicaltrials.gov/study/NCT06223841"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06223841","phase":"1/2","setting":"A Clinical Trial of Phase Ib/II to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors","sponsor":"SUNHO（China）BioPharmaceutical CO., Ltd.","enrolled":50,"outcomes":[]},"route":"/trials/nct06223841/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}